Skip to main content
Postgraduate Medical Journal logoLink to Postgraduate Medical Journal
. 1981 Feb;57(664):84–88. doi: 10.1136/pgmj.57.664.84

Control of osteitis deformans using glucagon, calcitonin, and mithramycin.

J R Condon, J Surtees, V Robinson
PMCID: PMC2424817  PMID: 6455656

Abstract

Glucagon, porcine calcitonin, and mithramycin were given to patients with Paget's disease of bone. There was rapid complete relief of bone pain accompanied by biochemical improvement or normalization in all cases. Calcitonin and glucagon appear to have additive properties in Paget's disease and the use of the 3 drugs in combination may reduce the incidence of side effects and the development of "drug resistance". The cost of treatment might also be reduced if periodic treatment as demonstrated in Case 1 is used.

Full text

PDF
84

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bijvoet O. L., van der Sluys Veer J., Jansen A. P. Effects of calcitonin on patients with Paget's disease, thyrotoxicosis, or hypercalcaemia. Lancet. 1968 Apr 27;1(7548):876–881. doi: 10.1016/s0140-6736(68)90236-5. [DOI] [PubMed] [Google Scholar]
  2. Condon J. R. Glucagon in the treatment of Paget's disease of bone. Br Med J. 1971 Dec 18;4(5789):719–721. doi: 10.1136/bmj.4.5789.719. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Condon J. R., Reith S. B., Nassim J. R., Millard F. J., Hilb A., Stainthorpe E. M. Treatment of Paget's disease of bone with mithramycin. Br Med J. 1971 Feb 20;1(5746):421–423. doi: 10.1136/bmj.1.5746.421. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Frijlink W. B., Bijvoet O. L., te Velde J., Heynen G. Treatment of Paget's disease with (3-amino-1-hydroxypropylidene)-1, 1-bisphosphonate (A.P.D.). Lancet. 1979 Apr 14;1(8120):799–803. doi: 10.1016/s0140-6736(79)91318-7. [DOI] [PubMed] [Google Scholar]
  5. Haddad J. G., Jr, Birge S. J., Avioli L. V. Effects of prolonged thyrocalcitonin administration on Paget's disease of bone. N Engl J Med. 1970 Sep 10;283(11):549–555. doi: 10.1056/NEJM197009102831101. [DOI] [PubMed] [Google Scholar]
  6. Kivirikko K. I., Laitinen O., Prockop D. J. Modifications of a specific assay for hydroxyproline in urine. Anal Biochem. 1967 May;19(2):249–255. doi: 10.1016/0003-2697(67)90160-1. [DOI] [PubMed] [Google Scholar]
  7. Ryan W. G., Schwartz T. B., Perlia C. P. Effects of mithramycin on Paget's disease of bone. Ann Intern Med. 1969 Mar;70(3):549–557. doi: 10.7326/0003-4819-70-3-549. [DOI] [PubMed] [Google Scholar]
  8. Smith R., Russell R. G., Bishop M. Diphosphonates and Page's disease of bone. Lancet. 1971 May 8;1(7706):945–947. doi: 10.1016/s0140-6736(71)91447-4. [DOI] [PubMed] [Google Scholar]

Articles from Postgraduate Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES